5-Bromo-2,4-Dichloropyrimidine CAS 36082-50-5 Kuchena > 99.0% (GC) Palbociclib Intermediate Factory
Ruifu Chemical Supply Palbociclib Related Intermediates:
Palbociclib CAS 571190-30-2
5-Bromo-2,4-Dichloropyrimidine CAS 36082-50-5
5-Bromo-2-Chloro-N-Cyclopentylpyrimidin-4-Amine CAS 733039-20-8
tert-Butyl 4-(6-Nitropyridin-3-yl)piperazine-1-Carboxylate CAS 571189-16-7
tert-Butyl 4-(6-Amino-3-Pyridyl)piperazine-1-Carboxylate CAS 571188-59-5
6-Bromo-2-Chloro-8-Cyclopentyl-5-Methylpyrido-[2,3-d]pyrimidin-7(8H)-imwe CAS 1016636-76-2
2-Chloro-8-Cyclopentyl-5-Methyl-8H-Pyrido[2,3-d]pyrimidin-7-imwe CAS 1013916-37-4
Chemical Name | 5-Bromo-2,4-Dichloropyrimidine |
Nhamba yeCAS | 36082-50-5 |
Nhamba yeCAT | RF-PI1852 |
Stock Status | MuStock, Kugadzirwa Kunokwira Kusvika Matani |
Molecular Formula | C4HBRCl2N2 |
Molecular Weight | 227.87 |
Boiling Point | 128℃/15 mmHg (lit.) |
Density | 1.781 g/mL pa25℃ (lit.) |
Refractive Index | n20/D 1.603 (lit.) |
Solubility | Soluble muMethanol |
Brand | Ruifu Chemical |
Item | Zvinotsanangurwa |
Chitarisiko | Isina Ruvara kune Chiedza Yellow Liquid |
Kuchena / Analysis Method | >99.0% (GC) |
Melting Point | 29.0 ~ 30.0 ℃ |
Mvura (naKarl Fischer) | <0.50% |
2,4-Dichloropyrimidine | <0.50% (GC) |
Maximun Single Kusachena | <0.50% (GC) |
Zvose Zvisina Kuchena | <1.00% |
1 H NMR Spectrum | Zvinoenderana Nechimiro |
Test Standard | Enterprise Standard |
Usage | Pakati pePalbociclib (CAS: 571190-30-2) |
Package: Fluorinated Bhodhoro, 25kg / Drum, kana zvinoenderana nezvinodiwa nemutengi
Storage Condition:Chengetedza mumidziyo yakavharwa panzvimbo inotonhorera uye yakaoma;Dzivirira kubva kuchiedza uye unyoro
5-Bromo-2,4-Dichloropyrimidine (CAS: 36082-50-5) inogona kushandiswa sekutanga reagent ye synthesis yezvakanaka allosteric modulators yeGABAB receptors (zvinodhaka-sekirasi yemishonga) uye pyridinepyrimidine analogs.5-Bromo-2,4-Dichloropyrimidine inogona kushandiswa sepakati pePalbociclib (CAS: 571190-30-2).Palbociclib (inozivikanwawo senhamba yekomboni PD-0332991) mushonga wekuedzwa wekurapa gomarara rezamu uri kugadzirwa nePfizer.Palbociclib inosarudza inhibitor ye cyclin-inotsamira kinases CDK4 uye CDK6.